Ultra Nasdaq Biotechnology 2X ETF (BIB)

N/A +N/A (N/A)
Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume N/A
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts N/A
Price Target N/A

Company Profile

The index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies. Under normal circumstances, the fund will obtain leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.

masterofcharts
masterofcharts May. 8 at 9:12 PM
$BIB https://www.wavegenius.com/p/deep-dive-bib-5yr-chart-breakout-3-of-3-targets-1-618-and-2-618
0 · Reply
jjon2121
jjon2121 May. 8 at 11:33 AM
$XBI $LABU $LABD $IBB $BIB Found 2 more buyout announcements. Roche/Pathai 5/7 1.05B https://www.bioworld.com/articles/730966-roche-to-acquire-pathai-for-up-to-1.05b Angelini/Catalyst 5/7 4B https://www.biopharmadive.com/news/angelini-catalyst-acquisition-cns-drugs/819591/
1 · Reply
jjon2121
jjon2121 May. 4 at 11:24 AM
$XBI $LABU $LABD $IBB $BIB Two more buyouts announced since the previous buyout list was posted. Esperion Therapeutics is being acquired by healthcare investment firm Archimed in a deal worth up to $1.1 billion. 5/1. UCB to acquire Candid in $2.2B bet on bispecifics for autoimmune diseases. 5/4 https://www.biopharmadive.com/topic/biotech/ That takes the total over 20B since 4/27. So where is the buyout boost? Previous Buyouts posted: Teva/Emalex 4/29 700M biopharmadive.com/news/teva... Chiesi/KalVista 4/29 1.9B biopharmadive.com/news/chie... Thermo Fisher/Astorg 4/28 1.075B bioworld.com/articles/73067... Don't forget Sun pharma/Organon 4/27 11.75B bioworld.com/articles/73078... Lilly/Ajax on 4/27 2.3b biopharmadive.com/news/lill...
2 · Reply
jjon2121
jjon2121 Apr. 29 at 7:09 PM
$XBI $LABU $LABD $IBB $BIB Buyouts out of the woodworks: Over 17B last 3 days. Since 4/17, S&P hasn't dropped any. XBI down 8% IBB down 6.5% BIB down 13.6%. Where are you MMs? Buyouts: Teva/Emalex 4/29 700M https://www.biopharmadive.com/news/teva-emalex-acquisition-deal-tourette-drug-biotech/818827/ Chiesi/KalVista 4/29 1.9B https://www.biopharmadive.com/news/chiesi-kalvista-deal-acquire-hereditary-angioedema-ekterly/818798/ Thermo Fisher/Astorg 4/28 1.075B https://www.bioworld.com/articles/730672-thermo-fisher-sells-microbiology-business-for-1b Don't forget Sun pharma/Organon 4/27 11.75B https://www.bioworld.com/articles/730787-sun-pharma-to-acquire-merck-spinoff-organon-for-11.75b Lilly/Ajax on 4/27 2.3b https://www.biopharmadive.com/news/lilly-ajax-deal-acquire-jak-myelofibrosis-drug/818523/
2 · Reply
jjon2121
jjon2121 Apr. 28 at 9:46 AM
$XBI $LABU $LABD $BIB $IBB 2 new buyout announcements for bio. One small, one big. Lilly/Ajax 2.3B https://stkt.co/UrHKF14S Sun Pharma/Organon 11.75B https://stkt.co/1RW3kXb7
3 · Reply
howardlindzon
howardlindzon Apr. 12 at 6:07 PM
I dont understand most of what elliot talks about on his newsletter the 'century of biology' but It Is a good read as ai enters the sector a lot to prove https://centuryofbio.com/p/eroom?utm_source=post-email-title&publication_id=323104&post_id=178897767&utm_campaign=email-post-title&isFreemail=true&r=ndh&triedRedirect=true&utm_medium=email $IBB $BIB
1 · Reply
howardlindzon
howardlindzon Apr. 12 at 12:17 AM
$BIB $IBB I have to think ai offres so many tailwinds to biotech not sure what other etf's cobver this space so chime In please
1 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 1 at 5:39 PM
$BIB RSI: 56.62, MACD: -1.3438 Vol: 3.37, MA20: 79.24, MA50: 83.19 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Merlin333
Merlin333 Mar. 13 at 1:56 PM
I have been saying and will say it again on $IVVD shares are tight, very tight. $IBB $XBI $BIB $QQQ
0 · Reply
Merlin333
Merlin333 Mar. 12 at 1:17 PM
$IVVD These are stats I look for, sub-5 #Phase3 Active Positions Holders Shares Increased Positions 75 114,960,406 Decreased Positions 27 12,588,461 Held Positions 23 123,924,350 As you can see institutions were busy in Q4! $IBB $XBI $BIB $SPY
0 · Reply
Latest News on BIB
Here is a List of Small-Cap Biotech ETFs to Watch for Big Gains in 2026

2026-02-19T19:18:15.000Z - 2 months ago

Here is a List of Small-Cap Biotech ETFs to Watch for Big Gains in 2026

CRBU CRNX GNOM HRTS REGN VKTX VRTX

masterofcharts
masterofcharts May. 8 at 9:12 PM
$BIB https://www.wavegenius.com/p/deep-dive-bib-5yr-chart-breakout-3-of-3-targets-1-618-and-2-618
0 · Reply
jjon2121
jjon2121 May. 8 at 11:33 AM
$XBI $LABU $LABD $IBB $BIB Found 2 more buyout announcements. Roche/Pathai 5/7 1.05B https://www.bioworld.com/articles/730966-roche-to-acquire-pathai-for-up-to-1.05b Angelini/Catalyst 5/7 4B https://www.biopharmadive.com/news/angelini-catalyst-acquisition-cns-drugs/819591/
1 · Reply
jjon2121
jjon2121 May. 4 at 11:24 AM
$XBI $LABU $LABD $IBB $BIB Two more buyouts announced since the previous buyout list was posted. Esperion Therapeutics is being acquired by healthcare investment firm Archimed in a deal worth up to $1.1 billion. 5/1. UCB to acquire Candid in $2.2B bet on bispecifics for autoimmune diseases. 5/4 https://www.biopharmadive.com/topic/biotech/ That takes the total over 20B since 4/27. So where is the buyout boost? Previous Buyouts posted: Teva/Emalex 4/29 700M biopharmadive.com/news/teva... Chiesi/KalVista 4/29 1.9B biopharmadive.com/news/chie... Thermo Fisher/Astorg 4/28 1.075B bioworld.com/articles/73067... Don't forget Sun pharma/Organon 4/27 11.75B bioworld.com/articles/73078... Lilly/Ajax on 4/27 2.3b biopharmadive.com/news/lill...
2 · Reply
jjon2121
jjon2121 Apr. 29 at 7:09 PM
$XBI $LABU $LABD $IBB $BIB Buyouts out of the woodworks: Over 17B last 3 days. Since 4/17, S&P hasn't dropped any. XBI down 8% IBB down 6.5% BIB down 13.6%. Where are you MMs? Buyouts: Teva/Emalex 4/29 700M https://www.biopharmadive.com/news/teva-emalex-acquisition-deal-tourette-drug-biotech/818827/ Chiesi/KalVista 4/29 1.9B https://www.biopharmadive.com/news/chiesi-kalvista-deal-acquire-hereditary-angioedema-ekterly/818798/ Thermo Fisher/Astorg 4/28 1.075B https://www.bioworld.com/articles/730672-thermo-fisher-sells-microbiology-business-for-1b Don't forget Sun pharma/Organon 4/27 11.75B https://www.bioworld.com/articles/730787-sun-pharma-to-acquire-merck-spinoff-organon-for-11.75b Lilly/Ajax on 4/27 2.3b https://www.biopharmadive.com/news/lilly-ajax-deal-acquire-jak-myelofibrosis-drug/818523/
2 · Reply
jjon2121
jjon2121 Apr. 28 at 9:46 AM
$XBI $LABU $LABD $BIB $IBB 2 new buyout announcements for bio. One small, one big. Lilly/Ajax 2.3B https://stkt.co/UrHKF14S Sun Pharma/Organon 11.75B https://stkt.co/1RW3kXb7
3 · Reply
howardlindzon
howardlindzon Apr. 12 at 6:07 PM
I dont understand most of what elliot talks about on his newsletter the 'century of biology' but It Is a good read as ai enters the sector a lot to prove https://centuryofbio.com/p/eroom?utm_source=post-email-title&publication_id=323104&post_id=178897767&utm_campaign=email-post-title&isFreemail=true&r=ndh&triedRedirect=true&utm_medium=email $IBB $BIB
1 · Reply
howardlindzon
howardlindzon Apr. 12 at 12:17 AM
$BIB $IBB I have to think ai offres so many tailwinds to biotech not sure what other etf's cobver this space so chime In please
1 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 1 at 5:39 PM
$BIB RSI: 56.62, MACD: -1.3438 Vol: 3.37, MA20: 79.24, MA50: 83.19 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Merlin333
Merlin333 Mar. 13 at 1:56 PM
I have been saying and will say it again on $IVVD shares are tight, very tight. $IBB $XBI $BIB $QQQ
0 · Reply
Merlin333
Merlin333 Mar. 12 at 1:17 PM
$IVVD These are stats I look for, sub-5 #Phase3 Active Positions Holders Shares Increased Positions 75 114,960,406 Decreased Positions 27 12,588,461 Held Positions 23 123,924,350 As you can see institutions were busy in Q4! $IBB $XBI $BIB $SPY
0 · Reply
Merlin333
Merlin333 Mar. 11 at 6:03 PM
$BIB $IBB $IVVD $QQQ $XBI Let’s goooooo Bulls
0 · Reply
Merlin333
Merlin333 Mar. 11 at 3:01 PM
$IVVD Massive Buying! Just saying $QQQ $IBB $XBI $BIB
0 · Reply
Merlin333
Merlin333 Mar. 11 at 2:07 PM
$IVVD Risk vs. Reward stock sub-5, back over 1.91 and close we are headed back towards testing resistance at 2.24 on 5x potential $IBB $XBI $BIB
0 · Reply
Merlin333
Merlin333 Mar. 10 at 1:36 PM
$IVVD 250k shares purchased GO TIME $IBB $SPY $XBI $BIB
0 · Reply
Merlin333
Merlin333 Mar. 10 at 1:04 PM
$IVVD The appointment of Dr. Michael Mina as Chief Medical Officer (CMO) on March 5, 2026, has been viewed as a positive strategic catalyst by the market. Analysts suggest his background in infectious disease and public communication will strengthen the company's clinical execution and market education efforts. Consensus Rating: Wall Street maintains a "Strong Buy" consensus for IVVD. Price Targets: Analysts have set an average price target of $8.75, with some reaching as high as $10.00, suggesting significant potential upside. $IBB $XBI $BIB $SPY
1 · Reply
Merlin333
Merlin333 Mar. 9 at 1:52 PM
$IVVD We are turning the corner on to Bullish! https://fintel.io/so/us/ivvd 50-day ma is 1.88 and over 2 coming soon They are doing the right things and sub 2 is a Risk vs. Reward Gift IMO 90% shares owned by the "Big Boys" institutions with a limited amount available to trade if things go right. They need to DCA too and if retail gets involved we ROCKET! $IBB $XBI $BIB $SPY
0 · Reply
Merlin333
Merlin333 Mar. 6 at 2:54 PM
$IVVD Looking at the 90% of shares owned by the "big Boys" and trading 1.80, if others want in it has to go up because who wants to sell. It is not easy building a large position at this point. $IBB $XBI $BIB https://whalewisdom.com/stock/adgi
0 · Reply
Merlin333
Merlin333 Mar. 6 at 2:42 PM
$IVVD Invivyd, more and more shares are getting eaten up and being held. We will get through 3's pretty fast soon $IBB $XBI $BIB $SPY
0 · Reply
Merlin333
Merlin333 Mar. 5 at 8:12 PM
$IVVD look at the $XBI & $BIB getting crushed, we might crack 1.80 close
0 · Reply
Merlin333
Merlin333 Mar. 5 at 12:24 PM
$IVVD http://archive.fast-edgar.com/20260305/AQ2ZK22CZZ2RBJZ222ZG2ZYNMDBIZZ22N88Q $SPY $IBB $XBI $BIB
0 · Reply
Merlin333
Merlin333 Mar. 3 at 6:56 PM
$IVVD Well if you’re roll the dice trader this could payoff with Thursday ER and update on phase 3 trial $IBB $XBI $BIB $SPY
1 · Reply
Merlin333
Merlin333 Mar. 3 at 4:19 PM
$IVVD I'm just speculating, but in the stock market environment I believe announcing ER for Thursday morning 3/5/26 when they could have waited may mean GOOD NEWS!!! Time will tell $IBB $XBI $BIB $SPY
0 · Reply